Immunoclin (Immunoclin) Asset Impairment Charge : $0.00 Mil (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Asset Impairment Charge?

Immunoclin's Asset Impairment Charge for the three months ended in Oct. 2014 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00 Mil.

Immunoclin Asset Impairment Charge Historical Data

The historical data trend for Immunoclin's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Asset Impairment Charge Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Asset Impairment Charge

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Asset Impairment Charge	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Immunoclin Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Immunoclin's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines